Top 10 Summer Stocks
OptionsZone Experts, May 22, 2009
Free Trading Guides
-
Top Summer Stock #8: Gilead Sciences
It's never pleasant to think about illness, particularly when you'd rather be out having fun this summer. But harmful biological forces are always among us, even when we'd rather forget about them. Fortunately, there is one great company that's always thinking about how to combat diseases—biopharmaceutical firm Gilead Sciences (GILD) .
GILD is already wildly profitable, and it continues growing north of 20% per year. The company receives a 20% royalty on flu treatment drug Tamiflu, and with the recent swine flu scare, sales of the drug are likely to surge. Gilead also has several promising drugs slated for release later this year. This stock was one of the few that held up well through the 2008 meltdown, and it will likely remain strong regardless of the whims of the overall market. So, not only can Gilead protect your health with its drug therapies, the shares may also help your portfolio stay healthy.
More By This Expert
Chris Johnson
Why Does My Call Decline When the Stock Gains?
Understanding the factors that affect option pricing is crucial to your trading success.
Use a Strangle to Profit From Starbucks' Earnings
Starbucks has been a big mover -- up and down -- after earnings, and the company is schedule to report today after the close A strangle creates a win-win for traders.
The earnings projections for Starwood Hotels (HOT) are ridiculously low. Get in before they blow expectations out of the water.
Bullish call activity in YHOO is hitting highs for the year ahead of earnings -- but when they announce it will be a wake, not a party.
XOM may hit earnings estimates, but a big, positive reaction is not likely to materialize, and the newbies will fall over themselves to dump the stock.
